Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

宾夕法尼亚州AUDUBON - 市值118.1亿美元、在InvestingPro获得"优秀"财务健康评级的肌肉骨骼解决方案公司Globus Medical, Inc. (NYSE: GMED)已同意以约2.5亿美元现金收购专注于慢性疼痛治疗的全球医疗设备公司Nevro Corp. (NYSE: NVRO)。根据今日宣布的收购协议，Globus ...

基于这些考虑，BTIG分析师Zimmerman重申对Globus Medical股票的买入评级，目标价为91.00美元，反映了对公司增长轨迹和Nevro Corp收购预期收益的信心。该股目前的交易价格接近52周高点94.93美元， InvestingPro 分析显示，根据其专有公允价值模型，该股票估值合理。

Globus Medical (GMED), a musculoskeletal solutions company, Thursday agreed to acquire Nevro Corp. (NVRO), a medical device company, ...

Globus Medical (GMED) and Nevro Corp. (NVRO) have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an ...

Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...

Montgomery County's Globus Medical has agreed to acquire a California life sciences company focused on treating chronic pain ...

Globus Medical said the purchase would increase its portfolio of musculoskeletal technologies, therefore enhancing its position in neuromodulation and chronic pain management. Nevro, with its ...

Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...

While Nevro recorded income of around $408 million, Globus Medical's sales at $2.52 billion showed a 60.6% annual rise year ...